Article

Bacteria-Triggered Botulism Outbreak Suspected at Mississippi Federal Prison

Author(s):

Officials reported that a recent outbreak of botulism affecting 20 inmates at a prison in Mississippi was possibly linked to drinking moonshine.

Officials reported that a recent outbreak of botulism affecting 20 inmates at a prison in Mississippi was possibly linked to drinking moonshine.

According to the CDC, botulism is a potentially fatal illness triggered by the bacterium Clostridium botulinum, commonly found in soil and water.

More than a dozen convicts from the Yazoo City Correctional Institution remain hospitalized, and all inmates were treated with an anti-toxin.

While toxicology reports are still pending, investigators believe the inmates began falling ill from drinking homemade alcohol.

Officials are also investigating the contents of this specific drink. But, often referred to as “hooch” or “pruno,” the contraband brew is typically made from fruit and vegetable scraps, sugar, and water.

The disease onset usually occurs between six hours to 10 days following drink consumption. Symptoms include blurred vision, muscle weakness, fatigue, difficulty swallowing, and slurred speech.

Additionally, serious cases of botulism can lead to death from respiratory failure.

The only inmates at risk are those who rank the beverage. Although botulism can’t be spread from person to person, officials have suspended family visitation to the medium-security prison until further notice.

The rare, but serious paralytic disease causes about 145 cases of human illness in the US annually. A quarter of the incidents result from food, and only 3-5% of patients die, the CDC reported.

Related Videos
Advocating for Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD
Duloxetine for Patients with COPD Suffering from Comorbid Depression
Looking at This Year in Pulmonology: A Lungcast 2024 Recap
Christine Frissora, MD | Credit: Weill Cornell
How to Manage Aspirin-Exacerbated Respiratory Disease
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
© 2025 MJH Life Sciences

All rights reserved.